ASPN
ASPEN AEROGELS INC
NYSE · Industrials · Construction · US
$5.52
+1.47%Year over year
Reported trailing growth
- Revenue
- -49.1%
- EBITDA
- +74.5%
- EBIT
- +66.4%
- EPS
- +59.8%
- Free cash flow
- +1238.5%
- Operating cash flow
- -15.5%
Forward estimates
Based on analyst estimates
- Revenue
- +33.5%
- EBITDA
- +134.5%
- EPS
- +83.7%
Three-year CAGR
- Revenue
- +14.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +88.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026